STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 79 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $28,000 | -71.1% | 11,591 | -52.9% | 0.00% | – |
| Q2 2020 | $97,000 | +162.2% | 24,589 | +24.8% | 0.00% | – |
| Q1 2020 | $37,000 | +362.5% | 19,710 | +1327.2% | 0.00% | – |
| Q2 2018 | $8,000 | -96.1% | 1,381 | -94.1% | 0.00% | – |
| Q1 2018 | $206,000 | +32.1% | 23,272 | +8.1% | 0.00% | – |
| Q4 2017 | $156,000 | +18.2% | 21,530 | +12.7% | 0.00% | – |
| Q3 2017 | $132,000 | +1785.7% | 19,098 | +1921.0% | 0.00% | – |
| Q2 2017 | $7,000 | +40.0% | 945 | -7.5% | 0.00% | – |
| Q1 2017 | $5,000 | +150.0% | 1,022 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -60.0% | 1,022 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | +25.0% | 1,022 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | -20.0% | 1,022 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | – | 1,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,376,039 | $47,309,000 | 51.34% |
| Lyon Street Capital, LLC | 3,182,149 | $28,162,000 | 9.07% |
| Opaleye Management Inc. | 1,590,000 | $14,071,000 | 4.02% |
| Broadfin Capital, LLC | 2,793,752 | $24,725,000 | 3.85% |
| Vivo Capital, LLC | 1,918,132 | $16,975,000 | 2.40% |
| ARMISTICE CAPITAL, LLC | 3,372,000 | $29,842,000 | 2.28% |
| PRECEPT MANAGEMENT LLC | 470,000 | $4,160,000 | 1.73% |
| NEA Management Company, LLC | 4,141,308 | $36,651,000 | 1.63% |
| Harvest Capital Strategies LLC | 825,000 | $7,301,000 | 1.14% |
| Granite Point Capital Management, L.P. | 567,895 | $5,026,000 | 0.49% |